Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19
A pooled analysis of over 11,000 patients showed an adverse event profile comparable to placebo (Tuthill et al., Ann N Y Acad Sci 2010)
Hormonal shifts: Declines in growth hormone, estrogen, or testosterone affecting metabolism
[PubMed: 16517403] 118
Without these proteins we become deficient
Contraindications Based on mechanisms and theoretical considerations, BPC-157 may not be appropriate for: Individuals with active cancer Pregnant or breastfeeding women Those with uncontrolled cardiovascular conditions People taking anticoagulant medications (effects on bleeding unknown) Individuals with autoimmune conditions (immune modulation effects unclear) Quality and Purity Concerns Perhaps the most significant safety concern involves product quality
Sermorelin Acetate - Warnings and Laboratory Tests (FDA Prescribing Information)
US$ 23.71
US$ 21.95
US$ 26.56
US$ 24.87
US$ 29.83
